




Adverse events due to cancer treatment (changes in weight, reduced muscle capacity and 
mobility) hinder the quality of life (QoL) of cancer survivors. Nevertheless, the identification of 
discriminative predictors of QoL in post-menopausal women (PW) survivors of gynecological 
cancer (PW-SGC) has been ignored. Objective: The purpose of the present study was to examine 
the role of muscle capacity, mobility and body mass index (BMI) on the deterioration of QoL in PW 
(n = 35; 62.1 ± 8.2 years) and PW-SGC (n = 51; 60.8 ± 11.4 years). Methods: The QoL questionnaire 
(SF-36), anthropometrical evaluation (BMI), hand-held dynamometry (HHD) and short physical 
performance battery (SPPB) were applied in all volunteers. Results: The participants had 
overweight, low SF-36 scores and normal HHD, and no significant differences were found between 
both groups, however the SPPB score was higher in the PW group (p < 0.001). Linear regression 
analyses for QoL indicated the BMI (beta = -0.27) and the SPPB (beta = 0.57) were the strongest 
and most significant predictors in PW and PW-SGC, respectively. The area under the curve (AUC) 
for the SPPB score was 0.74 (95% CI: 0.57-0.87; P = 0.015) in the PW-SGC group and 0.62 (95% 
CI: 0.47-0.75; P = 0.181) in PW. Conclusion: The present study showed that the importance of 
BMI and mobility (SPPB) for QoL differ between PW and PW-SGC. For PW-SGC, the strongest 
independent predictor of QoL was mobility (SPPB), whereas BMI was the strongest contributor in 
PW. Moreover, the SPPB test is a discriminative predictor (or assessment tool) for identifying the 
low quality of life in postmenopausal women survivors of gynecological cancer.
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O Short Physical Performance Battery é uma ferramenta 
discriminativa para identificar baixa qualidade de vida 
em mulheres na pós-menopausa sobreviventes do câncer 
ginecológico 
RESUMO
Efeitos adversos do tratamento (modificações da massa corporal e reduções da capacidade 
muscular e mobilidade) podem modificar a qualidade de vida (QV) de sobreviventes de 
câncer. Semelhantemente, a menopausa e o envelhecimento podem promover alterações 
antropométricas e da função física. Portanto, torna-se necessário o levantamento de ferramentas 
para predizer, distintamente, a QV em mulheres na pós menopausa (PM) e em mulheres na pós 
menopausa sobreviventes de câncer ginecológico (PMSCG). Objetivo: Examinar a contribuição da 
força, mobilidade e do índice de massa corporal (IMC) sobre as alterações da QV em PM (n = 35; 
62,1±8,2 anos) e PMSCG (n = 51; 60,8±11,4 anos). Métodos: Aplicou-se questionário de QV (SF-
36), avaliação antropométrica (IMC), dinamometria de preensão manual (DPM) e short physical 
performance battery (SPPB). Resultados: Participantes apresentaram sobrepeso, baixo score em 
SF36 e DPM normal, sem diferenças entre os grupos.  O score de SPPB foi maior em PM (p<0,001). 
Análise de regressão linear de QV, indicou IMC (beta = -0,27) e o SPPB (beta = 0,57), como os 
mais fortes preditores em PM e PMSCG, respectivamente. A área sob a curva para o score do 
SPPB foi 0,74 (95% CI: 0,57-0.87; P = 0,015) em PMSCG e 0,62 (95% CI: 0,47-0,75; P = 0,181) em 
PM. Conclusão: O presente estudo demonstrou que para PMSCG o principal preditor da QV foi a 
mobilidade (SPPB), enquanto o IMC foi o mais forte contribuidor em PM. Portanto, o SPPB é um 
teste específico para identificar reduções na QV pacientes sobreviventes de câncer ginecológico.
Palavras-chave: Envelhecimento, Limitação da Mobilidade, Índice de Massa Corporal, Dinamôme-
tro de Força Muscular, Sobreviventes de Câncer
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INTRODUCTION 
Although the most common treatments 
(surgery, radiation therapy, and systemic 
therapy) in cancer have documented survival 
advantage, the implications for quality of 
life may not be negligible.1-3 Depending on 
the location, extent, and duration these 
treatments may cause various adverse events 
(e.g. pain, fatigue, low functional capacity) in 
cancer survivors.1-5 These adverse events can 
become persistent for years, impacting on 
quality of life (QoL) of cancer survivors.2-6
Excess weight body weight (body mass 
index; BMI), low muscle strength and low 
mobility (changing body positions, carrying 
or moving objects, or walking and moving) 
alterations have been shown to be critical 
determinants of independent functioning, a 
central tenet of QoL in cancer survivors.2,3,7 
However, those alterations in BMI, muscle 
strength and mobility have also been observed 
in postmenopausal (PW) and older women 
who did not have cancer,8 making difficult 
our understanding of a relationship between 
adverse effects of cancer treatment and 
risk for low QoL in PW gynecological cancer 
survivors (PWGCS). 
Little attention has been given to 
identification of discriminative predictors to a 
low quality of life in PWGCS. To the best of our 
knowledge, no study has examined the specific 
contribution of muscle strength, mobility, 
and BMI to deterioration of QoL in PW and 
PWGCS separately. As the identification of 
discriminative predictors to QoL is critical for 
advancing our understanding of a relationship 
between adverse events of cancer treatment 
and risk for a low quality of life, the lack of 
this information delineates the importance 
of examining strength, mobility and obesity 
in PW and PWGCS separately. Moreover, early 
identification of discriminative predictors to 
a low QoL may be a key issue in preventing 
low QoL2-6,9 in PWGCS. Thus, an appropriate 
discriminative predictor for identifying people 
at risk for a low QoL progression in the near 
future is important, particularly in routine 
clinical care.
OBJETIVE
The purpose of the present study was 
to examine the contribution of strength, 
mobility, and BMI to deterioration of QoL in 
PW and PWGCS separately. We hypothesized 
that PWGCS would have different predictors 
for QoL when compared to PW.
METHODS
This cross-sectional study was concluded 
with 86 women, attended between January 
and November of 2015 in Breast and 
Gynecologic Clinic at the Hospital of the 
Federal University of Triângulo Mineiro, 
Brazil. All volunteers included were PW aged 
50 or older, characterized by spontaneous 
amenorrhea for at least 12 months, radical 
hysterectomy surgery or endocrine therapy 
(anastrozole and tamoxifen). The inclusion 
criteria consisted of: No hormone replacement 
therapy or phytoestrogens and no several 
physical limitations (wheelchair, canes or any 
similar device). The initial evaluation consisted 
of an interview about behavioral habits, 
history of illnesses and medicine intake. After 
the QoL questionnaire (SF-36) was applied. 
Finally, all the volunteers were submitted to 
an anthropometrical evaluation and physical 
performance tests: hand-held dynamometry 
(HHD) and the short physical performance 
battery (SPPB). All selected women agreed 
with the terms of the study and signed the 
free and informed consent approved by the 
Research Ethics Committee of the Federal 
University of Triângulo Mineiro, Brazil (n. 
1090676).
Anamnesis
Preliminarily, all volunteers were submitted 
to anamnesis to detect age, labor situation, 
indicators of health and history of past and 
present illnesses and medicinal intake. It was 
identified 35 PWCGS (breast cancer, 54.9%; 
uterine cervical cancer, 29.4%; endometrial 
cancer, 5.9%; ovarian cancer, 5.9% and vaginal 
cancer, 3.9%). Medicine intake included lipid-
lowering drugs (statins and fibrates), blood-
pressure-lowering drugs (beta blockers, 
calcium blocker channel, diuretics and ACE 
blockers) glucose-lowering drugs (insulin and 
metformin), anti-inflammatory drugs (AINES), 
anti-depressive drugs and estrogen blockers 
(tamoxifen).
Quality of life questionaire SF-36
The SF-36 consisted of a multidimensional 
questionnaire consisting of 36 items 
encompassed in eight scales or components: 
functional capacity, physical aspects, pain, 
general health, vitality, social functioning, 
emotional aspects and mental health. For 
each component, there is a final score of zero 
to 100, where zero is the worst general health 
status and 100 the best state of health, the 
sum of all components compromises of zero 
to 800.10
Anthropometric and body composi-
tion assessments
Body weight and height were measured 
with a digital scale (Lider®, Brazil) and a 
stadiometer fixed to the scale, respectively. 
The BMI was classified according to the system 
used by the World Health Organization.
Physical performance tests
All physical tests were performed in the 
following order: HHD and SPPB.The HHD test 
was measured with a manual dynamometer 
(Jamar®, Brazil) to detect global muscle 
strength in the right hand. Three measures 
were taken and the mean was calculated as 
the valid measure.11
The SPPB consisted of three tests to detect 
mobility and the tests were performed in the 
following order: balance test, four-meters 
walk test (FMWT) and five-time-sit-to-stand 
test (FTSST). Each test score varied to zero to 
four points, and the SPPB scorer varied to zero 
to 12 points (sum of the scores of the three 
tests).12
The balance test consisted of three 
positions: Side-by-Side Stand, Semi-Tandem 
Stand, and Tandem Stand. The score was 
based on the time hold (10 seconds) in each 
position.
The FMWT test was evaluated by the time 
walked in a distance of four meters which 
the volunteer auto selected the velocity. Two 
measures were taken and the minor time was 
considered as the valid measure.
The FTSST test was evaluated by the time 
spent in five maximum velocity squats in a 
chair with the arms folded across the chest. 
The technique consisted of full sit and stand 
position and the volunteer started in the sit 
position.
Statistical analysis
Data distribution was determined using 
the D’Agostino-Person test. The data are 
presented as mean and standard deviation 
(SD). T-test was used to compare groups (PW 
and PWGCS). Multiple regression analysis 
was used to associate variables independents 
(BMI, HHD and SPPB score) with variable 
dependent (QoL score). Receiver operating 
characteristic (ROC) curves and area under 
the curve (AUC) analysis were used to assess 
the accuracy of SPPB in determining QoL. 
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The lowest quartile of QoL was coded in both 
groups to determine the AUC. The significant 
level was set at p<0.05.
RESULTS 
At first, the baseline clinical characteristics 
of groups were interpreted and statistically 
compared (Table 1). The age values were 
within the normal range for PW, and there 
was no difference between groups. In mean 
values, the participants showed overweight 
(i.e BMI > 24.9 kg/m2), low SF36 and normal 
HHD (i.e. > 20 kg), with no differences between 
groups. The participants showed normal SPPB 
score (i.e. score > 6); however, there was a 
difference between groups and the SPPB score 
was higher in the PW group.
Condition-specific linear regression 
analyses, performed to examine the relative 
importance of predictor variables for QoL 
in PWGCS and PW, indicated that the 
strongest predictors of QoL differed between 
conditions (Table 2). In PW, BMI was the 
significant predictor after adjustment for 
age. Each standard deviation increase in BMI 
was associated with a mean QoL (standard 
deviation) decrease of 27 %. In PWGCS, SPPB 
was the significant predictor of QoL; each 
standard deviation increase in SPPB was 
associated with a mean QoL increase of 57 %.
Measures of diagnostic accuracy (ROC 
curves and AUC) of the SPPB and QoL in 
PWGCS and PW are shown in Figure 1A and B, 
respectively. The AUC for the SPPB score was 
0.74 (95% confidence interval [CI]: 0.57–0.87; 
P = 0.015) in PWCGS. In PW, the AUC for the 
SPPB score was 0.62 (95% confidence interval 
[CI]: 0.47–0.75; P = 0.181).
DISCUSSION
The major findings from this study 
suggest that the relative importance of 
status of weight (BMI) and mobility (SPPB) 
for QoL differ between PW and PWGCS. 
For PWGCS, the strongest independent 
predictor of QoL was SPPB, whereas BMI 
was the strongest contributor in PW. Thus, 
the SPPB test is a discriminative predictor 
(or tool) for identifying a low quality of life 
in postmenopausal women gynecological 
cancer survivor. This study contributes to 
the literature by presenting novel findings 
regarding the specific contributors that impact 
QoL in PWGCS and PW.
To the best of our knowledge, this is the 
first study that examined the importance of 
BMI, muscle strength, and mobility to QoL 
in condition-specific analyses of PW and 
PWGCS. We observed that the SPPB test was 
the strongest independent predictor of QoL, 
whereas BMI was the strongest contributor 
in PW. Moreover, we found that the SPPB test 
was suitable for identifying PWGCS with low 
QoL, but was not for PW. 
Because limitations in mobility are often 
the first signs of further functional decline, 
9,13,14 the lower SPPB values and the negative 
association between SPPB and QoL observed 
solely in PWGCS suggest that development of 
limitations in mobility is a premature event in 
the course of PWGCS, leading to low QoL.2,3 As 
the common treatments in cancer have been 
reported to reduce muscle mass in cancer 
patients, 2,3,7,15 PW with gynecological cancer 
may not recovery muscle after treatments.16-22 
A sexually dimorphic effect of aging on skeletal 
muscle protein synthesis has been shown by 
Smith et al.17,19,23 Hence, it has been suggested 
that PW are less responsive to physiological 
muscle growth stimuli (nutrition and physical 
activity) than older men, suggesting that 
older women exhibit poor muscle recovery 
following disuse-related muscle loss.20-22 
Thus, our results are important because the 
identifying of a discriminative predictor to poor 
mobility has been advocated as a key issue in 
preventing disability 9 and consequently low 
QoL in PWGCS. 
Unlike the results observed in SPPB 
test, the results from analyses of the HHD 
showed that this was not a relevant factor in 
the discrimination of QoL in PWGCS. These 
results suggest that lower extremity strength 
(SPPB) might be more relevant than upper 
extremity strength (HHD) to QoL in PWGCS. 
It has been shown that lower body extremity 
strength is important for functional activities 
in older adult,24 an important predictor of 
QoL in cancer survivors.2,3,7 The SPPB test 
had the highest value for predicting low QoL 
because the cluster of tests in SPPB (standing 
balance tests, Five-Times-Sit-to-Stand Test, 
and 4-meter gait speed) is to assess the lower 
body extremity physical function, which 
reflects the potential for daily life activities 
such as standing up from a sitting position and 
walking or carrying a bag. Moreover, although 
HHD strength is easy to apply and has low 
cost, the use of HHD as a predictor of lower 
body extremity strength has been unjustified 
by Samuel et al.24
Despite our findings that the SPPB 
showed good clinical validity, limitations 
should be noted. This study was restricted 
to a cross-sectional strategies and small 
sample; therefore, the discriminative ability 
of the SPPB may not be generalizable to 
different settings. In this context, future 
studies should consider these associations 
prospectively, and a large sample should be 
included. However, discriminative predictors 
can be well estimated from controlled 
studies. None of the controlled studies has 
been designated to determine discriminative 
predictors for identifying a low quality of life 
PWGCS (n = 35) PW (n = 51) Delta P*
Age, years 60.8±11.4 62.1±8.2 -1.3 0.537
BMI, kg/m2 29.6±5.9 29.1±5.9 0.5 0.719
FMWT, m/s 0.9±0.2 1.1±0.2 -0.2 0.000
FTSST, s 14.9±3.4 11.4 ±2.6 3.5 0.000
SPPB, total score 8.5±2.0 11.0±1.3 -2.5 0.000
HHD, kg 23.0±6.1 23.8±5.9 -0.7 0.567
SF36, total score 427.7±80.8 404.9±86.4 22.8 0.213
Table 1. Participant characteristics
Post-menopausal women (PW), PW gynecological cancer survivors (PWGCS), body mass index (BMI), Five-time-sit-to-stand test (FTSST), four-me-
ters walk test (FMWT), Short Physical Performance Battery (SPPB), hand-held dynamometry (HHD), Differences between groups (Delta). kg = kilo-
grams, m = meters, s = seconds, * = t test of student (independent)
 PWGCS (N=35) PW (N=51)
Beta SE P Beta SE P
BMI, kg/m2 -0.13 0.17 0.468 -0.27 0.13 0.049
SPPB, total 
score
0.57 0.21 0.013 0.20 0.14 0.154
HHD, kg 0.28 0.17 0.119 -0.04 0.15 0.798
Table 2. Independent predictors of SF36 from condition-specific linear regression analyses
Post-menopausal women (PW), PW gynecological cancer survivors (PWGCS), standard error (SE), short physical performance battery (SPPB), hand-
held dynamometry (HHD), body mass index (BMI).PWGCS and PW groups were adjusted to age. 
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in postmenopausal women gynecological 
cancer survivor, making our study important, 
particularly in routine clinical care. 
CONCLUSION
To sum up, our study showed that the 
relative importance of BMI and physical 
capacity for QoL differs between PW 
and PWGCS. For PWGCS, the strongest 
independent predictor of QoL was mobility 
(SPPB), whereas weight status (BMI) was the 
strongest contributor in PW. Moreover, the 
SPPB test is a discriminative predictor (or 
tool) for identifying a low quality of life in 
postmenopausal women gynecological cancer 
survivor.
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